http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0647136-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_12a9e9ce63eb0bbf3658453fb50a6d9b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f8dbdfc93841b3d731fbab7ea48b412a
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-44
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D221-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-435
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D221-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-472
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D217-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D519-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-00
filingDate 1993-06-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c77c5b5e28ff1cc4ec3c7ae50c75c1f7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_18673e46155fce5da7013c19613944ac
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_75390cfa4a56b28d78bf2fcbfe58cf41
publicationDate 1995-04-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-0647136-A1
titleOfInvention USE OF CONDENSED BIS- (3,4-DIHYDRO-PYRIDINYL) METHANE FOR THE TREATMENT OF MORBUS CROHN, COLITIS ULCEROSA, CHRONICALLY INFLAMMATORY PROCESSES AND AS AN ANTIPROLIFERATIVE AGENTS.
abstract Benzo- and thieno-3,4-dihydropyridine derivates having general formula (I), in which D stands for a group having formula (Ia), A and B standing for a benzo- or thieno residue, R2, R3, R5, R6, R7, R11, R12, m and n being as defined in the description, and their pharmaceutically tolerable salts, are used for preparing agents for treating chronic inflammatory processes, colitis ulcerosa and Crohn's disease, and antiproliferative agents.
priorityDate 1992-06-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396401
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID64965
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226415768
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID443953
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCC0HJC5
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57054
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID17804526
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226461214
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399906
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCC0HJD2
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID446378
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ3T478
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID70043162
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128056158
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226408288
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID232909674
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID20055127
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID232909730

Total number of triples: 44.